Remimazolam alleviates hepatic ischemia-reperfusion injury by activating FOXO1/3 signaling
Abstract Background Hepatic ischemia reperfusion injury (HIRI) frequently gives rise to aggravated liver damage. Currently, there exists a diverse range of anesthetic drugs that possess protective capabilities against ischemia-reperfusion injury (IRI). Nevertheless, the specific functions and underl...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2025-04-01
|
| סדרה: | BMC Gastroenterology |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12876-025-03820-3 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
